Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir in hospitalized serious influenza
NCT00958776Phase 3Terminated
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Nov 2009
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands
- Countries
- 23
01
Overview
A Phase 3 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Nov 2009; status: terminated.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00958776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958776.